INVENT_COVID.xlsx
收藏官方服务：
资源简介：
IV imatinib in moderate severe COVID-19 patients Conclusion of abstract:IV imatinib did not reduce pulmonary edema or improve clinical outcomes in invasively ventilated COVID-19 patients. While this trial does not support the use of imatinib in the general COVID-19 ARDS population, imatinib reduced pulmonary edema in a subgroup of patients, underscoring the potential value of predictive enrichment in ARDS trials.
提供机构：
Schippers, Job创建时间：
2024-10-03
